| http://www.w3.org/ns/prov#value | - Cellceutix Corporation (OTCBB: CTIX) (the Company), a biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases, is pleased to announce that the U.S. Food and Drug Administration (FDA) has completed the review of the Company's Investigational New Drug (IND) application for Kevetrin???, the C
|
